EMAIL THIS PAGE TO A FRIEND

Cell death & disease

Caspase-dependent cell death-associated release of nucleosome and damage-associated molecular patterns.


PMID 25356863

Abstract

Apoptosis, which is anti-inflammatory, and necrosis, which is pro-inflammatory, represent the extremes of the cell death spectrum. Cell death is complex and both apoptosis and necrosis can be observed in the same cells or tissues. Here, we introduce a novel combined mode of cellular demise--caspase-dependent regulated necrosis. Most importantly, it is mainly characterized with release of marked amount of oligo- or poly-nucleosomes and their attached damage-associated molecular patterns (DAMPs) and initiated by caspase activation. Caspase-activated DNase has dual roles in nucleosomal release as it can degrade extracellularly released chromatin into poly- or oligo-nucleosomes although it prohibits release of nucleosomes. In addition, osmotically triggered water movement following Cl(-) influx and subsequent Na(+) influx appears to be the major driving force for nucleosomal and DAMPs release. Finally, Ca(2+)-activated cysteine protease, calpain, is an another essential factor in nucleosomal and DAMPs release because of complete reversion to apoptotic morphology from necrotic one and blockade of nucleosomal and DAMPs release by its inhibition.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

16609
1,2-Bis(2-amino-5-methylphenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl) ester, ≥95% (HPLC)
C36H44N2O18
M0171
1-(Ethoxycarbonylmethyl)-6-methoxyquinolinium bromide
C14H16BrNO3
46123
1-(Ethoxycarbonylmethyl)-6-methoxyquinolinium bromide, suitable for fluorescence, ≥97.0% (TLC)
C14H16BrNO3
A7410
Amiloride hydrochloride hydrate, ≥98% (TLC), powder
C6H8ClN7O · HCl · xH2O
A1076
BAPTA-AM, ≥95% (HPLC)
C34H40N2O18
B3023
Bumetanide, ≥98%
C17H20N2O5S
B1158000
Bumetanide, European Pharmacopoeia (EP) Reference Standard
C17H20N2O5S
C4705
Calcium acetate hydrate, BioXtra, ≥99% (titration)
C4H6CaO4 · xH2O
379964
Calcium acetate hydrate, 99.99% trace metals basis
C4H6CaO4 · xH2O
C1000
Calcium acetate hydrate, ReagentPlus®, ≥99% (titration), powder
C4H6CaO4 · xH2O
21056
Calcium acetate hydrate, BioUltra, ≥99.0% (calc. on dried material, KT)
C4H6CaO4 · xH2O
25011
Calcium acetate hydrate, puriss., meets analytical specification of FCC, E263, 99.0-100.5% (based on anhydrous substance)
C4H6CaO4 · xH2O
402850
Calcium acetate monohydrate, ACS reagent, ≥99.0%
C4H6CaO4 · H2O
A6185
Calpain Inhibitor I, ≥97% (TLC), powder
C20H37N3O4
H4759
Hydrochlorothiazide, crystalline
C7H8ClN3O4S2
H2910
Hydrochlorothiazide, meets USP testing specifications
C7H8ClN3O4S2
H1200000
Hydrochlorothiazide, European Pharmacopoeia (EP) Reference Standard
C7H8ClN3O4S2
1314009
Hydrochlorothiazide, United States Pharmacopeia (USP) Reference Standard
C7H8ClN3O4S2
PHR1032
Hydrochlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material
C7H8ClN3O4S2
Y0001494
Hydrochlorothiazide for peak identification, European Pharmacopoeia (EP) Reference Standard
C7H8ClN3O4S2
PHR1324
Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material
C7H17NO5
66930
N-Methyl-D-glucamine, ReagentPlus®, ≥99.0% (T)
C7H17NO5
Y0001209
N-Methyl-D-glucamine, European Pharmacopoeia (EP) Reference Standard
C7H17NO5
N7143
Nigericin sodium salt, ≥98% (TLC)
C40H67NaO11
45713
TBTC, PESTANAL®, analytical standard
C12H27ClSn
T2265
Tetraethylammonium chloride, ≥98% (titration)
C8H20ClN
86614
Tetraethylammonium chloride, BioUltra, for molecular biology, ≥99.0% (AT)
C8H20ClN
86616
Tetraethylammonium chloride, for electrochemical analysis, ≥99.0%
C8H20ClN
T50202
Tributyltin chloride, 96%
C12H27ClSn
442869
Tributyltin chloride, analytical standard
C12H27ClSn